NCT01793480View on ClinicalTrials.gov

Evaluation of the Efficacy and Safety of Two Methadone Titration Methods for the Treatment of Cancer-related Pain With Inadequate Pain Relief or Intolerable Side Effects When Treated With Level 3 Opioids.

PHASE3CompletedINTERVENTIONAL
Enrollment

146

Participants

Timeline

Start Date

January 5, 2012

Primary Completion Date

May 6, 2014

Study Completion Date

August 31, 2014

Conditions
Pain Related to Cancer
Interventions
DRUG

Methadone

Trial Locations (16)

Unknown

Investigational Site 10, Amiens

Investigational Site 06, Bayonne

Investigational Site 13, Caen

Investigational Site 03, Gap

Investigational Site 11, Le Chesnay

Investigational Site 07, Lille

Investigational Site 16, Lyon

Investigational Site 12, Nice

Investigational Site 14, Paris

Investigational Site 02, Pierre-Bénite

Investigational Site 05, Reims

Investigational site 08, Strasbourg

Investigational Site 17, Suresnes

Investigational Site 01, Tarbes

Investigational Site 04, Toulouse

Investigational Site 15, Villejuif

All Listed Sponsors
lead

RECORDATI GROUP

INDUSTRY

NCT01793480 - Evaluation of the Efficacy and Safety of Two Methadone Titration Methods for the Treatment of Cancer-related Pain With Inadequate Pain Relief or Intolerable Side Effects When Treated With Level 3 Opioids. | Biotech Hunter | Biotech Hunter